[Overview of the prevalence and features of oncological diseases in type 2 diabetes and possible immunological mechanisms]. [PDF]
Probl Endokrinol (Mosk)Dvoryanchikov YV +3 more
europepmc +1 more source
[Adipocytokines: modern definition, classification and physiological role]. [PDF]
Probl Endokrinol (Mosk), 2021 Markova TN, Mishchenko NK, Petina DV.
europepmc +1 more source
[Use of human umbilical cord acellular matrix for soft tissue defects in patient with diabetic foot syndrome (case report)]. [PDF]
Probl Endokrinol (Mosk)Chebotarev SV +9 more
europepmc +1 more source
[Non-classical hormones from the fibroblast growth factor family]. [PDF]
Probl Endokrinol (Mosk)Gronskaia SA +3 more
europepmc +1 more source
[Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia]. [PDF]
Probl Endokrinol (Mosk), 2023 Shlyakhto EV +18 more
europepmc +1 more source
[Matrix metalloproteinases in pituitary adenoma invasiveness]. [PDF]
Probl Endokrinol (Mosk)Kutakova DV +3 more
europepmc +1 more source
[Characteristics of geriatric and somatic status in patients with osteoporosis]. [PDF]
Probl Endokrinol (Mosk), 2021 Khovasova NO +3 more
europepmc +1 more source
[Discordant parameters of insulin-like growth factor 1 and growth hormone in the diagnosis and monitoring of acromegaly]. [PDF]
Probl Endokrinol (Mosk), 2021 Sakhnova EE +3 more
europepmc +1 more source
[Cephalgic syndrome in patients with acromegaly]. [PDF]
Probl Endokrinol (Mosk)Nurullina GN +2 more
europepmc +1 more source
[Gene and cell therapy of adrenal pathology: achievements and prospects]. [PDF]
Probl Endokrinol (Mosk), 2021 Glazova OV +6 more
europepmc +1 more source